VoiceOver users please use the tab key when navigating expanded menus

ANZ announces special one-year fixed home loan rate

ANZ today announced it would drop its one-year fixed home loan rate to 2.79% p.a, and further reduce most other key home loan rates.

 

ANZ will also offer fixed-rate specials on 18-month (3.05% p.a), 2-year (2.95% p.a) and 3-year (3.35% p.a) term loans.

 

The new rates will be available from 21 May and will take fixed home loan rates “well beyond historic lows” said Ben Kelleher, ANZ Managing Director Retail and Business Banking.

 

“These new rates reflect a new reality where many home loan customers are facing uncertain times and our commitment to keeping rates as low as possible to help ease the pressure,” Mr Kelleher said.

 

“Putting more money back in the pockets of customers will enable them to repay debt, or support the wider New Zealand economy as the country recovers from restrictions brought on by Covid-19.”

 

No decision had been made on how long the rate would be available, but it would largely depend on market conditions.

 

Deposit rates will be reviewed at a later date. “As always, we will be working hard to balance the needs to borrowers and savers in setting new deposit rates, although this is challenging in the current low-interest-rate environment,” Mr Kelleher said.

 

For media enquiries contact Stefan Herrick on 021 748 492

 

Download PDF

related articles

ANZ lowers rates to support businesses

ANZ NZ announced it would decrease Commercial, Business and Agri Floating term loan, Flexi and Overdraft base rates by 0.75% in line with yesterday’s RBNZ emergency cash rate cut.

9 ways COVID-19 has re-shaped NZ's economy

ANZ Chief Economist provides 9 insights into how COVID-19 has reshaped New Zealand's economy.

Budget 2020 - Rebuilding in the wake of Covid-19

Insights from Finance Minister Hon Grant Robertson, ANZ NZ CEO Antonia Watson and Chief Economist Sharon Zollner on the Government’s Budget 2020 and its plans for rebuilding the economy in the wake of Covid-19.